In this video, Nikos Gorgoraptis (Imperial College London, UK) discusses the clinical importance of understanding tau pathology after traumatic brain injury, including the limitations surrounding molecular imaging techniques in the field.
The ENIGMA brain injury group – also referred to as the ENIGMA Consortium – is a global collaboration that brings…
Injected immune-modifying nanoparticles have been demonstrated to reduce swelling and secondary brain damage in mice following a traumatic brain injury.
In this video, Payam Barnaghi (University of Surrey, UK) discusses the application of artificial intelligence and neurotechnology into a healthcare setting for patients with traumatic brain injury.
Researchers have discovered that alterations in the gut microbiome of rats recovering from spinal cord injury could be associated with their mental health. This provides a lead to potentially treating mental health issues related to spinal cord injuries with bacteriotherapy.
At the 21st Spinal Research Network Meeting, we had the pleasure of speaking with Grégoire Courtine to hear more about the development of neurotechnologies for spinal cord injuries, including how close we might be to turning this rehabilitation paradigm into a treatment in the clinic.
Researchers have discovered a correlation between reaction time and white matter microstructure damage in patients with concussion, suggesting an alteration in signaling patterns as a result of mild traumatic brain injury.
Four studies presented at SfN Neuroscience have demonstrated how the microbiome interacts with the brain in mice, revealing the possible mechanisms behind gut–brain communication.
A low-cost and widely available drug, termed tranexamic acid, could reduce deaths from traumatic brain injury by ‘hundreds of thousands’, according to a recent study.
Researchers have suggested that traumatic microbleeds may be a form of injury to brain blood vessels that could predict worse outcomes following a head injury.